Report - ECIL 3 Empirical Antifungal Therapy Update 2009...Walsh, 2004 Caspo 50 3% Lipo AmB 3 11% 0.001 23 Impact of Empirical Antifungal Therapy in Different Clinical Settings 1. In AL vs.

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form